Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.2601
+0.0001 (0.04%)
Mar 31, 2025, 10:47 AM EDT - Market open
ELEV's stock price has decreased by -95.05% in the past year and price targets may not have had time to catch up.
Elevation Oncology Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$3.78
Upside
+1,353.29%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy → Hold Downgrades $5 | Buy → Hold | Downgrades | $5 | +1,822.34% | Mar 24, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $10 → $0.7 | Buy → Hold | Downgrades | $10 → $0.7 | +169.13% | Mar 21, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy → Hold Downgrades $7 | Buy → Hold | Downgrades | $7 | +2,591.27% | Mar 21, 2025 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $9 → $1 | Buy → Hold | Downgrades | $9 → $1 | +284.47% | Mar 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $1 | Strong Buy | Maintains | $6 → $1 | +284.47% | Mar 21, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $7 | Buy | Reiterates | $7 | +2,591.27% | Mar 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +2,206.81% | Mar 10, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $5 | Buy | Reiterates | $5 | +1,822.34% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +2,206.81% | Jan 14, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 3, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $7 | Buy | Reiterates | $7 | +2,591.27% | Dec 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +2,206.81% | Dec 13, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $5 | Buy | Reiterates | $5 | +1,822.34% | Dec 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +2,206.81% | Aug 7, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $7 | Buy | Reiterates | $7 | +2,591.27% | Jul 15, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $7 | Buy | Reiterates | $7 | +2,591.27% | Jun 28, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.